BACKGROUND
Air pollution has been proposed as a short-term trigger of multiple sclerosis (MS) relapses, but delayed effects remain poorly studied in the era of modern disease-modifying therapies (DMTs). We investigated whether weekly air pollution exposure was associated with delayed MS relapse risk up to 15 weeks.
M...
E. Januel, C. Papeix, A. Baudic et al.· Journal of Neurology Neurosu...· 0 citations
ABSTRACT Background Serum neurofilament‐light chain (sNfL) and glial fibrillary acidic protein (sGFAP) are associated with multiple sclerosis (MS) activity. This study aimed to identify patient‐ and disease‐level determinants of sNfL and sGFAP and to evaluate their ability to support differential diagnosis in neuromyel...
M. Rival, F. Rollot, Sabine Laurent-Chabalier et al.· European Journal of Neurolog...· 0 citations
BACKGROUND
Ofatumumab and ocrelizumab are widely used high-efficacy anti-CD20 therapies for relapsing-remitting multiple sclerosis (RRMS), but direct comparative evidence remains limited. We aimed to compare their effectiveness in routine clinical practice.
METHODS
We conducted an observational cohort study emulating...
Chao Zhu, S. Vukusic, T. Kalincik et al.· Journal of Neurology Neurosu...· 0 citations
Management of attacks as well as the prevention of relapses is crucial to limit functional sequelae and disability, and the rapid and individualized management of attacks is crucial to limit functional sequelae and disability.
L. Giorgi, R. Marignier, J. Pique et al.· Revue neurologique (Paris)· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.